Back to Search
Start Over
CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab
- Source :
- European Journal of Cancer. 97:59-61
- Publication Year :
- 2018
- Publisher :
- Elsevier BV, 2018.
- Subjects :
- 0301 basic medicine
Oncology
Cancer Research
medicine.medical_specialty
Skin Neoplasms
Hypophysitis
medicine.medical_treatment
Ipilimumab
Endocrine System Diseases
Thyroiditis
03 medical and health sciences
0302 clinical medicine
Cancer immunotherapy
Internal medicine
Genetic model
Biomarkers, Tumor
medicine
Humans
Endocrine system
CTLA-4 Antigen
Adverse effect
Melanoma
Polymorphism, Genetic
Endocrine disease
business.industry
Prognosis
medicine.disease
030104 developmental biology
Oncology, Cancer Research
business
030215 immunology
medicine.drug
Subjects
Details
- ISSN :
- 09598049
- Volume :
- 97
- Database :
- OpenAIRE
- Journal :
- European Journal of Cancer
- Accession number :
- edsair.doi.dedup.....8e7e2ba3ae943c555f333c5df2062c59
- Full Text :
- https://doi.org/10.1016/j.ejca.2018.04.005